Fougera Pharmaceuticals Inc. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection VAI · Mar 26, 2026
  • No warning letters matched by name
Inspections 26 0 OAI
Recalls 8 0 Class I (0%)
Warning letters 0 None on file
510(k) clearances 0 None on file

Fougera Pharmaceuticals Inc. has 8 FDA recalls, 26 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Fougera Pharmaceuticals Inc." is on file. FDA has published 1 Form 483 for Fougera Pharmaceuticals Inc..

What these totals cover: FDA records filed under the name "Fougera Pharmaceuticals Inc." and its spelling variant "Fougera Pharmaceuticals".

Latest recall
D-0612-2017 · Class II · Mar 2, 2017
Latest inspection
Mar 26, 2026 · VAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls8Nov 15, 2026File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections26Nov 17, 2026Newest record Nov 9, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Fougera Pharmaceuticals Inc.'s FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Fougera Pharmaceuticals Inc.: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2018: 2 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 2 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 2 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 2 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202610000
202500000
202400000
202320000
202220000
202100000
202000000
201920000
201820000
201700010

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Fougera Pharmaceuticals Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Fougera Pharmaceuticals Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Fougera Pharmaceuticals Inc. Form 483s

1 Form 483 published by FDA.

DateDocumentFEI
Mar 26, 2026 · Document on fda.gov 4832410271

A Form 483 lists the observations FDA investigators made at the end of an inspection. FDA publishes some Form 483s in its reading room, and each date links to that document. Read the observations with the FDA 483 search.

Recent recalls

8 recall records from Jun 7, 2012 to Mar 2, 2017.

NumberClassProductDate
D-0612-2017Class IIDesonide Ointment, 0.05%, NET WT 60 grams tubes, Rx only, E. FOUGERA & CO. A division of Fougera…Mar 2, 2017
D-0245-2015Class IIFLUOCINONIDE GEL USP, 0.05%, Rx only, For External Use Only, Not For Ophthalmic Use, a) NET WT 15…Aug 28, 2014
D-1441-2014Class IIITriamcinolone Acetonide Lotion USP, 0.025%, 60 mL Bottle, Rx Only, For Dermatologic Use Only, Not…Jul 3, 2014
D-1440-2014Class IIITriamcinolone Acetonide Lotion USP, 0.1%, 60 mL Bottle, Rx Only, For Dermatologic Use Only, Not for…Jul 3, 2014
D-1152-2014Class IIITriamcinolone Acetonide Cream USP, 0.1%, Net Wt 80 grams per tube, Rx only, E. Fougera & Co., A…Jan 29, 2014
D-1044-2014Class IIIKETOCONAZOLE CREAM, 2%, 30 gram tube, Rx only, E. FOUGERA & CO., A division of Fougera…Nov 18, 2013
D-241-2013Class IIIFougera Ketoconazole Cream 2%, 15g tube, Rx only, Labeled with E. Fougera & Co., a division of…Jul 18, 2012
D-1426-2012Class IIIErythromycin Topical Solution USP, 2%, 60 mL bottle with applicator, Rx only. E. FOUGERA & CO., A…Jun 7, 2012

Recent FDA inspections

26 inspections from Feb 6, 2009 to Mar 26, 2026. Showing the 20 most recent. View all 26 inspections

DateSiteProductClassificationFEI
Mar 26, 2026Hicksville, NYVeterinaryVoluntary Action Indicated (VAI)2410271
Dec 8, 2023Melville, NYVeterinaryNo Action Indicated (NAI)2432435
Nov 17, 2023Hicksville, NYVeterinaryVoluntary Action Indicated (VAI)2410271
Aug 10, 2022Melville, NYVeterinaryVoluntary Action Indicated (VAI)2432435
Aug 10, 2022Hicksville, NYDrugsVoluntary Action Indicated (VAI)2410271
Aug 8, 2019Melville, NYVeterinaryVoluntary Action Indicated (VAI)2432435
Aug 8, 2019Hicksville, NYDrugsVoluntary Action Indicated (VAI)2410271
May 29, 2018Hicksville, NYVeterinaryVoluntary Action Indicated (VAI)2410271
May 29, 2018Melville, NYDrugsVoluntary Action Indicated (VAI)2432435
Nov 10, 2016Hicksville, NYDrugsVoluntary Action Indicated (VAI)2410271
Nov 10, 2016Melville, NYDrugsVoluntary Action Indicated (VAI)2432435
Dec 23, 2014Melville, NYVeterinaryVoluntary Action Indicated (VAI)2432435
Dec 23, 2014Hicksville, NYDrugsVoluntary Action Indicated (VAI)2410271
Dec 20, 2013Hicksville, NYVeterinaryVoluntary Action Indicated (VAI)2410271
Oct 31, 2013Melville, NYDrugsVoluntary Action Indicated (VAI)2432435
Nov 16, 2012Hicksville, NYDrugsVoluntary Action Indicated (VAI)2410271
Nov 16, 2012Melville, NYDrugsVoluntary Action Indicated (VAI)2432435
Jun 15, 2012Melville, NYDrugsVoluntary Action Indicated (VAI)2432435
Feb 1, 2012Hicksville, NYDrugsVoluntary Action Indicated (VAI)2410271
Feb 9, 2011Melville, NYDrugsVoluntary Action Indicated (VAI)2432435
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

3 inspected sites, newest inspection first.

FacilityLocationInspectionsLatest
FEI 2410271Hicksville, NY13Mar 26, 2026
FEI 2432435Melville, NY12Dec 8, 2023
FEI 3004595406Mechanicsburg, PA1Jun 2, 2009

Fougera Pharmaceuticals Inc. and the FDA: common questions

Has Fougera Pharmaceuticals Inc. received an FDA warning letter?

No FDA warning letter addressed to the name "Fougera Pharmaceuticals Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Fougera Pharmaceuticals Inc. received an FDA Form 483?

FDA has published 1 Form 483 for Fougera Pharmaceuticals Inc. in its reading room, the most recent dated Mar 26, 2026. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Fougera Pharmaceuticals Inc.?

The most recent FDA inspection on file ended Mar 26, 2026 at Hicksville, NY and was classified VAI. FDA has 26 inspections of Fougera Pharmaceuticals Inc. on file.

Has Fougera Pharmaceuticals Inc. had an FDA recall?

Yes. Fougera Pharmaceuticals Inc. has 8 FDA recalls on record. The most recent started Mar 2, 2017.

Need more than this page shows? Ask about Fougera Pharmaceuticals Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.